Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapy

Affiliations

• ¹ a Department of Internal Medicine , Albert Schweitzer Hospital , Dordrecht , The Netherlands.
• ² b Department of Research , Netherlands Comprehensive Cancer Organisation (IKNL) , Utrecht , The Netherlands.
• ³ c Department of Public Health , Erasmus University Medical Centre , Rotterdam , The Netherlands.
• ⁴ d Department of Hematology , Erasmus MC Cancer Institute , Rotterdam , The Netherlands.
• ⁵ e Department of Immunology , Erasmus University Medical Centre , Rotterdam , The Netherlands.
• ⁶ f Department of Clinical Chemistry , Result laboratories, Albert Schweitzer Hospital , Dordrecht , The Netherland.
• ⁷ g Department of Hematology , Academic Medical Centre , Amsterdam , the Netherlands.